Back to the complete issue
Thursday, 16 December 2021

Gavi looks set to rely more on Pfizer / BioNTech jabs in 2022

The Health Ministry reported 879 new covid-19 infections yesterday, up from 822 the day before. Egypt has now disclosed a total of 371,698 confirmed cases of covid-19. The ministry also reported 48 new deaths, bringing the country’s total death toll to 21,203.

Morocco has its first Omicron case: The Moroccan Health Ministry announced yesterday that it recorded its first Omicron case — a Moroccan citizen in the city of Casablanca, who is currently receiving treatment in hospital. Two days prior to the case being confirmed, the country had extended its travel ban on all inbound international flights until 31 December.

Pfizer / BioNTech are set to dethrone AstraZeneca as the main global supplier of covid vaccines through the Gavi / Covax program by the beginning of next year, according to Reuters. Covax has so far delivered over 600 mn jabs to around 150 countries, 220 mn of which were AstraZeneca and 160 mn were Pfizer. But jabs manufactured by the US firm will soon take the lead as the program starts to rely more heavily on vaccine donations from rich nations, which are mostly giving away Pfizer shots. Some 150 mn Pfizer jabs will be donated to Covax by the end of 1Q2022, according to documents from the World Health Organization seen by the newswire.

Sanofi is pushing its covid-19 vaccine release to 1Q2022 instead of this year, as the vaccine maker, which has partnered with GlaxoSmithKline on its covid vaccine, waits on the results of its late-stage clinical trials. The French pharma giant was one of the world’s largest vaccine makers before covid but its development of covid-19 jabs has lagged far behind its competitors, and it now hopes it can capitalize on the growing market for booster shots.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.